Radius Health Archives -

Roche revealed in its first-quarter results statement that giredestrant missed the mark in the phase 2 acelERA trial

Roche’s oral SERD giredestrant fails breast cancer trial

https://pharmaphorum.com/news/roches-oral-serd-giredestrant-fails-breast-cancer-trial/

Pfizer has pledged a whopping $1 billion upfront for rights to an Arvinas drug for breast cancer from

Pfizer puts up $1bn to buy into Arvinas breast cancer programme

https://pharmaphorum.com/news/pfizer-puts-up-1bn-to-buy-into-arvinas-breast-cancer-programme/

But romosozumab missed secondary endpoint of non-vertebral fractures

Amgen/UCB reveal new osteoporosis drug data

https://pharmaphorum.com/news/amgenucb-reveal-new-osteoporosis-drug-data/

Radius Health